Physician profile
Haley Miller
NPI 1467133215
$2,727.09
in general payments reported to CMS, 2019-2025
11 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $12.72 · 2024: $2,259 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,164 · Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,164.09 |
| Food and Beverage | $563.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,191.84 | 2024 | Supera |
| Abbvie INC. | $215.78 | 2025 | |
| Exact Sciences Corporation | $90.07 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $60.43 | 2025 | Farxiga, Breztri |
| Novo Nordisk INC | $58.73 | 2024-2025 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $25.90 | 2025 | Arexvy, Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $20.23 | 2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.15 | 2025 | Jardiance |
| Astellas Pharma US INC | $16.76 | 2025 | Veozah |
| Lilly USA, LLC | $15.10 | 2025 | Zepbound, Mounjaro |
| Xeris Pharmaceuticals, INC. | $13.10 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.